Since there are no known cases of fatal adenovirus infections in complement-deficient patients, it would be interesting to investigate whether TRIM21 is important in combating adenovirus infection in the immunocompetent host; however, as of yet, there are no case studies of patients with known TRIM21 deficiency. The gene discussed is TRIM21; the disease is adenoviridae infectious disease.